{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:34Z","timestamp":1774485514979,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007173","name":"Bio-oriented Technology Research Advancement Institution","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007173","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Tropical Medicine, Nagasaki University, Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.016","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T15:00:22Z","timestamp":1387897222000},"page":"864-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tricomponent fusion complex comprising a viral antigen, a pentameric \u03b1-helical coiled-coil, and an immunoglobulin-binding domain as an effective antiviral vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Takeshi","family":"Arakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Harakuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senji","family":"Tafuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Tadano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.12.016_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2011.10.007","article-title":"Boosting antibody responses by targeting antigens to dendritic cells","volume":"33","author":"Caminschi","year":"2012","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.imbio.2006.05.021","article-title":"Targeting antigens to dendritic cells in vivo","volume":"211","author":"Tacken","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0020","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1128\/IAI.05214-11","article-title":"Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development","volume":"79","author":"Miyata","year":"2011","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-5793(94)80239-4","article-title":"The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83","volume":"341","author":"Efimov","year":"1994","journal-title":"FEBS Letters"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1006\/jmbi.1997.1265","article-title":"High-resolution solution NMR structure of the Z domain of staphylococcal protein A","volume":"272","author":"Tashiro","year":"1997","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.micinf.2011.09.004","article-title":"Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice","volume":"14","author":"Tafuku","year":"2012","journal-title":"Microbes and Infection\/Institut Pasteur"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0040","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria","volume":"23","author":"Malkin","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0045","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1098\/rstb.2011.0106","article-title":"Innate immunity and adjuvants","volume":"366","author":"Akira","year":"2011","journal-title":"Philosophical Transactions of the Royal Society of London Series B, Biological Sciences"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0050","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","article-title":"Innate immunity mediates follicular transport of particulate but not soluble protein antigen","volume":"188","author":"Link","year":"2012","journal-title":"Journal of Immunology (Baltimore, MD: 1950)"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ces.2012.04.001","article-title":"Modular engineering of a microbially-produced viral capsomere vaccine for influenza","volume":"103","author":"Wibowo","year":"2013","journal-title":"Chemical Engineering Science"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/erv.10.140","article-title":"Adjuvants: no longer a \u2018dirty little secret\u2019, but essential key players in vaccines of the future","volume":"10","author":"Arakawa","year":"2011","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0070","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.016_bib0075","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/092986609789353709","article-title":"Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to porcine stable kidney cells","volume":"16","author":"Verma","year":"2009","journal-title":"Protein and Peptide Letters"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:56:16Z","timestamp":1589219776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13017477"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tricomponent fusion complex comprising a viral antigen, a pentameric \u03b1-helical coiled-coil, and an immunoglobulin-binding domain as an effective antiviral vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}